TwinStrand Biosciences Announces Filing of Patent Infringement Lawsuit Against Guardant Health
TwinStrand Biosciences, Inc. announced today that it filed a patent infringement lawsuit against Guardant Health, Inc. (Nasdaq: GH).
- TwinStrand Biosciences, Inc. announced today that it filed a patent infringement lawsuit against Guardant Health, Inc. (Nasdaq: GH).
- TwinStrand and its exclusive licensor, the University of Washington, filed the lawsuit in the United States District Court in Delaware.
- The complaint alleges that Guardant Health infringes multiple patents covering TwinStrands proprietary Duplex Sequencing methods for generating highly accurate DNA sequence data.
- TwinStrand Biosciences is leading the way in identifying ultra-low frequency genomic variants that are undetectable by conventional methods.